Judy K. Shigenaga - Concepedia

Author

Judy K. Shigenaga

Also Known As

J K Shigenaga, J Shigenaga, J. K. Shigenaga, J. Shigenaga, JUDY KWAN SHIGENAGA, Judy K Shigenaga, Judy K. Shigenaga, Judy Kwan Shigenaga, Judy Shigenaga

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco San Francisco VA Medical Center San Francisco VA Health Care System

About

Judy K. Shigenaga is an author at University of California, San Francisco specializing in medicine, inflammation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	38	3.8K
2	Health Sciences	16	16	1.4K
3	Allergy	4	4	149
4	Natural Sciences	1	1	28
5	Social Sciences	1	1	87

Judy K. Shigenaga

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Carl Grünfeld, M Pang, William T. Doerrler, The Journal of Clinical Endocrinology & Metabolism Primary ImmunodeficiencyInflammationMetabolic SyndromeLipid DisorderMedicine	1992	811
Mechanisms of triglyceride accumulation in activated macrophages Kenneth R. Feingold, Judy K. Shigenaga, Mahmood R. Kazemi, Journal of Leukocyte Biology Macrophage ActivationImmunologyInflammationMetabolic SyndromeAutophagy	2012	246
Inflammation stimulates the expression of PCSK9 Kenneth R. Feingold, Arthur H. Moser, Judy K. Shigenaga, Biochemical and Biophysical Research Communications InflammationCytokineAutoimmune DiseaseImmunologyImmune Regulation	2008	225
The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver Anne P. Beigneux, Arthur H. Moser, Judy K. Shigenaga, Journal of Biological Chemistry	2000	221
Role for circulating lipoproteins in protection from endotoxin toxicity Kenneth R. Feingold, Janet L. Funk, Arthur H. Moser, Infection and Immunity Lipid PeroxidationImmunologyOxidative StressInflammationMetabolic Syndrome	1995	211
Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response Anne P. Beigneux, Arthur H. Moser, Judy K. Shigenaga, Biochemical and Biophysical Research Communications Molecular PharmacologyPregnane X ReceptorBiochemistryAcute Phase ResponseMouse Liver	2002	184
Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPARγ, LXRα, and the coactivators SRC-1, PGC-1α, and PGC-1β in liver cells Min Sun Kim, Trevor R. Sweeney, Judy K. Shigenaga, Metabolism InflammationCytokineTumor Necrosis FactorHepatologyLiver Physiology	2007	167
Endotoxin and Cytokines Increase Hepatic Sphingolipid Biosynthesis and Produce Lipoproteins Enriched in Ceramides and Sphingomyelin Riaz A. Memon, Walter M. Holleran, Arthur H. Moser, Arteriosclerosis Thrombosis and Vascular Biology	1998	164
Repression of Farnesoid X Receptor during the Acute Phase Response Min Sun Kim, Judy K. Shigenaga, Art Moser, Journal of Biological Chemistry	2003	151
Adipocyte Fatty Acid–Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists Mahmood R. Kazemi, Carol M. McDonald, Judy K. Shigenaga, Arteriosclerosis Thrombosis and Vascular Biology	2005	143

Page 1